Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New treatment options in COPD.

Daniel E Hilleman1

  • 1Creighton University School of Pharmacy, 2500 California St., Omaha, NE 68178, USA. hilleman@creighton.edu

Journal of Managed Care Pharmacy : JMCP
|July 7, 2005
PubMed
Summary

Long-acting bronchodilators are key for managing chronic obstructive pulmonary disease (COPD). Tiotropium offers significant benefits in lung function, quality of life, and reducing exacerbations for COPD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lp(a): A potentially modifiable cardiovascular risk factor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Assessing pharmacists' knowledge and practices involving dietary supplement omega-3 fatty acids.

Journal of clinical lipidology·2025
Same author

Drug Interactions With Excessive Daytime Sleepiness Treatments.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2025
Same author

A narrative review of drugs targeting inflammation in vascular disease.

Postgraduate medicine·2025
Same author

A Clinicians Guide to Recommending Common Cholesterol-Lowering Dietary Supplements.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2024
Same author

Elevated Lp(a): Guidance for Identifying and Managing Patients.

Southern medical journal·2024

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) management requires effective long-term treatment strategies.
  • Adherence to medication is crucial for the efficacy of COPD therapies.

Purpose of the Study:

  • To review the role of long-acting bronchodilators in COPD treatment.
  • To emphasize the importance of treatment adherence in COPD management.

Main Methods:

  • Review of clinical trial data on long-acting bronchodilators for COPD.
  • Analysis of spirometric measures, quality of life, and exacerbation rates.

Main Results:

  • Tiotropium significantly improves spirometry, quality of life, and reduces exacerbations compared to placebo and ipratropium.
  • Tiotropium shows greater spirometric and quality-of-life improvements than salmeterol.
  • Fluticasone/salmeterol combination improves spirometry and dyspnea more than monotherapy but does not reduce exacerbations.

Conclusions:

  • Long-acting bronchodilators are recommended for maintenance COPD therapy due to superior effectiveness and convenience.
  • Inhaled tiotropium is effective for COPD and may be a first-line maintenance therapy.
  • Once-daily tiotropium administration likely enhances patient adherence and overall treatment efficacy.

Related Experiment Videos